Pharma

• WACKER and CordenPharma Achieve Pandemic Readiness in June 2024

  23 June 2024

  CDMOPharma

  

  The consortium will produce 80 million mRNA vaccine doses annually if needed, following a successful expansion and qualification phase, ensuring pandemic readiness for at least five years.
• Heinlein Plastik-Technik Joins ALPLA Group

  17 June 2024

  PolymersPharma

  

  The acquisition expands ALPLApharma's capabilities in closure systems and injection molding, enhancing product offerings and creating a technology center in Ansbach.
• Merck Invests €62M in New Quality Control Facility

  11 June 2024

  SpecialtiesCDMOPharma

  

  The new 10,000 sqm facility in Darmstadt will house 135 employees, meet sustainability standards, and enhance quality control for life science products, supporting Merck's €1.5B investment program.
• WACKER Launches mRNA Center in Halle, Germany

  3 June 2024

  CDMOPharma

  

  The new facility in Halle enables large-scale mRNA production, creating over 100 jobs and supporting Germany's pandemic preparedness with a capacity for 200 million vaccine doses annually.
• Asahi Kasei to Acquire Calliditas Therapeutics for SEK 11.8 Billion

  29 May 2024

  Pharma

  

  The acquisition will be executed through a voluntary tender offer, with major shareholders committed. It aligns with Asahi Kasei’s strategy to expand in healthcare, focusing on R&D and unmet medical needs.

• Roquette to Acquire IFF Pharma Solutions

  19 March 2024

  Pharma

  

  The acquisition will enhance Roquette's pharma product range, expand its US footprint, and boost its formulation and R&D capabilities, aiming to close by H1 2025 pending regulatory approval.
• Daiichi Sankyo Invests €1 Billion to Expand Pfaffenhofen Site into Innovation Center

  16 February 2024

  Pharma

  

  The Pfaffenhofen site will develop cancer therapies, create 350 jobs by 2030, and enhance ADC technology. The expansion includes new labs, renewable energy use, and collaboration with local partners.
• PanTera and Bayer Sign Actinium-225 Supply Agreement

  13 February 2024

  CDMOPharma

  

  Starting in late 2024, PanTera will supply actinium-225, enhancing access for clinical trials and developing a large-scale production facility to meet global demand for radiopharma-based cancer treatments.
• Global Bioenergies Sets Timeline for Biobased Isobutene Plant in France

  21 December 2023

  Biobased & CircularPharma

  

  The plant, using a "direct pathway" process, will be operational by 2027. It will produce isobutene for cosmetics and sustainable aviation fuels, with initial financing secured and engineering design to be finalized by 2024.
• Alkermes to Sell Athlone Facility to Novo Nordisk

  14 December 2023

  Pharma

  

  The $92.5M sale includes a subcontracting period until 2025. Alkermes aims for operational efficiency, while Novo Nordisk gains manufacturing capacity and 400 skilled employees.
• Novo Nordisk Invests €2.1 Billion in Expanding French Production Facilities

  23 November 2023

  Pharma

  

  The €2.1 billion investment will double the Chartres site's capacity, add new production processes, and create over 500 jobs by 2028, enhancing Novo Nordisk's ability to meet future medicine demands.
• Novo Nordisk to Invest €5.6 Billion in Expanding Danish Manufacturing Facilities

  10 November 2023

  CDMOPharma

  

  The €5.6 billion investment will expand API and packaging capacity, create 800 jobs, and enhance sustainability. Completion is expected between 2025-2029, with 3,000 external workers during construction.
• Lonza to Add New ADC Filling Line at Stein Facility

  13 October 2023

  CDMOPharma

  

  The new cGMP filling line will enhance bioconjugate handling and create 115 jobs by 2027, expanding end-to-end ADC manufacturing capabilities and supporting clinical and commercial supply.
• BioNTech Acquires InstaDeep to Enhance AI-Driven Drug Development

  31 July 2023

  Pharma

  

  The acquisition adds 290 skilled professionals and supports AI-driven drug discovery. InstaDeep will continue serving global clients in various sectors as a UK-based subsidiary. Total deal value: €500 million.
• Global Bioenergies Expands Isobutene Plant Plans in France

  27 July 2023

  Biobased & CircularPharma

  

  The new plant will produce 10,000 tonnes of isobutene annually, targeting cosmetics and sustainable aviation fuel markets. Construction schedules will be released by the end of 2023.
• Novo Nordisk to Invest €2.1bn in Danish Manufacturing Expansion

  12 June 2023

  CDMOPharma

  

  The €2.1bn investment will expand API production in Hillerød, creating 340 jobs by 2029. The facility will enhance production capacity, flexibility, and sustainability for future chronic disease treatments.
• BASF Expands Alkoxylate Production in Europe

  6 June 2023

  SpecialtiesPharma

  

  The expansion boosts capacity by over 150,000 metric tons annually, enhancing supply security and flexibility for European customers in various industries, including detergents, automotive, and construction.
• WACKER Acquires ADL Biopharma to Boost Biotechnology Business

  8 May 2023

  SpecialtiesCDMOPharmaFood

  

  The acquisition expands fermentation capacity by 2,000 cubic meters, enhances recovery and purification processes, and aims to grow customer relationships in food, pharmaceutical, and consumer goods sectors.
• Dexcom to Build First European Plant in Galway, Ireland

  5 May 2023

  Pharma

  

  The new facility in Galway will create up to 1,000 high-skilled jobs, supported by the Irish Government, and focus on automated, green technologies for continuous glucose monitoring.
• Lonza Expands Drug Product Manufacturing in Visp

  29 March 2023

  CDMOPharma

  

  The new cGMP line in Visp is operational, with first batches in April 2023. It supports clinical and commercial needs, enhancing end-to-end solutions and complementing recent site expansions.
• Sandoz to Build New Biologics Plant in Slovenia

  9 March 2023

  CDMOPharma

  

  The $400M investment aims to boost biosimilar production, with operations starting in 2026. This supports the company's growth in biosimilars and antibiotics, enhancing access to critical medicines.
• Moderna to Develop Innovation and Technology Centre at Harwell Campus

  5 March 2023

  Pharma

  

  The new centre will focus on mRNA vaccine R&D and manufacturing, creating jobs and boosting the UK's life sciences sector. Construction starts in 2023, with operations expected by 2025.
• Getinge to Establish UK Headquarters in Derby

  24 February 2023

  SpecialtiesPharma

  

  The new facility will house chemistry and decontamination operations, a training academy, and a showroom. It aims to boost local employment and economic growth, with operations starting in August 2023.
• Lonza Expands Bioconjugation Facility in Visp

  16 February 2023

  CDMOPharma

  

  The expansion includes two new manufacturing suites, enhancing capabilities for clinical and commercial supply, and increasing process, analytical development, and quality control capacity.
• Merck Invests €130 Million to Expand Manufacturing in Molsheim, France

  8 September 2022

  Pharma

  

  The investment will boost single-use assembly production, create 800 jobs by 2028, and support growth in novel therapies and vaccines, aligning with sustainability goals and global expansion plans.
• MetaboGen and BioGaia Open Pilot Plant for New Bacterial Strains in Sweden

  29 August 2022

  PharmaFood

  

  The new pilot plant in Eslöv will enable controlled fermentation and manufacturing of next-gen probiotic strains, supporting clinical studies and product development for commercialization.
• Novartis to Spin Off Sandoz into Standalone Company

  25 August 2022

  Pharma

  

  The spin-off aims to create a leading European generics and global biosimilars company, enhancing focus and growth for both entities, with completion expected in H2 2023, subject to approvals.